Phase 3 Type 2 Diabetes Mellitus Clinical Trials
11 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–11 of 11 trials
Recruiting
Phase 3
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Obesity or OverweightType 2 Diabetes Mellitus
Hoffmann-La Roche1,600 enrolled36 locationsNCT07351058
Recruiting
Phase 3
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
Chronic Kidney DiseasesType 2 Diabetes Mellitus
Prokidney685 enrolled95 locationsNCT05099770
Recruiting
Phase 3
Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes Mellitus
Type 2 Diabetes Mellitus
EMS270 enrolled1 locationNCT04670666
Recruiting
Phase 3
Current Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes
Type 2 Diabetes Mellitus
Nanjing First Hospital, Nanjing Medical University1,000 enrolled1 locationNCT06825182
Recruiting
Phase 3
A Study of BGM0504 in Poorly Controlled Type 2 Diabetes Patients Only Through Diet and Exercise
Type 2 Diabetes Mellitus (T2DM)
BrightGene Bio-Medical Technology Co., Ltd.207 enrolled1 locationNCT06716203
Recruiting
Phase 3
A Study of BGM0504 in Participants with Type 2 Diabetes
Type 2 Diabetes Mellitus (T2DM)
BrightGene Bio-Medical Technology Co., Ltd.537 enrolled1 locationNCT06716216
Recruiting
Phase 3
RCT Glargine vs NPH for Treatment of DM in Pregnancy
Type 2 Diabetes Mellitus (T2DM)Diabetes Mellitus in PregnancyGestational Diabetes Mellitus, Class A2
Loyola University160 enrolled1 locationNCT06619301
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of BR1019A and BR1019B Combination Therapy
Essential HypertensionType 2 Diabetes Mellitus
Boryung Pharmaceutical Co., Ltd276 enrolled2 locationsNCT06220773
Recruiting
Phase 3
A Study to Investigate the Effect of DWP16001 as add-on Therapy to Drug A in Patients With Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus
Daewoong Pharmaceutical Co. LTD.240 enrolled1 locationNCT05466643
Completed
Phase 3Phase 4
Improved treatment of type 2 diabetes mellitus by improving the splenic functions and gastro intestinal tract using naturally occurring bioactive compounds
gastrointestinal disorderSplenic and gastro intestinal disorder in Type 2 Diabetes Mellitus
Nguyen Van Toan94 enrolled1 locationACTRN12614000007639
Active
Phase 3
The combined effect of Liraglutide and Sleeve Gastrectomy on Metabolic, Cardiac, Neurological and Sleep Function in Obese Diabetes: A Twelve-Month Randomised Study.
ObesityType 2 Diabetes Mellitus
Northern Sydney Local Health District120 enrolled1 locationACTRN12613001069741